Bli medlem
Bli medlem

Du är här

2016-10-28

Elos Medtech AB: Elos Medtech - subscription of warrants

The management and key employees within the Elos Medtech Group has
signed a total of 251,500 warrants in the incentive program 2016/2019
that the Annual General Meeting decided on in April, 2016.

At the Annual General Meeting of Elos Medtech AB, April 26 2016, it
was decided to implement an incentive program whereby a maximum of
318,473 warrants can be transferred to senior executives and key
employees within the Elos Medtech Group. A total of 251,500 warrants
were subscribed, of which 63,000 warrants were signed by CEO Jan
Wahlström.

In accordance with the AGM's decision, the subscription price upon
exercise of the warrants was set at SEK 147 per share. This is
equivalent to 150 percent of the volume-weighted average closing
price of the Company share on the NASDAQ Stockholm, during the period
of 10 trading days following the date of the Annual General Meeting
April 26 2016. The price of the warrants has been calculated at
market value using the Black & Scholes model and amounted to 5.67
SEK/warrant. Subscription of shares shall take place between October
1 and December 31, 2019.

If all the Group's now 318,473 outstanding warrants are exercised, the
total dilution amounts to about 5% and 2% of the votes in the
Company.

Lidköping, October 28, 2016

Elos Medtech AB (publ)

For further information, please contact: Christian Bergaust, CFO, +46
70 293 50 40, christian.bergaust@elosmedtech.com

This information is information that Elos Medtech AB (publ) is obliged
to make public pursuant to the EU Market Abuse Regulation. The
information was submitted for publication, through the agency of the
contact person set out above on October 28, 2016, at 17:00 (CET).

For additional information about the Elos Medtech Group, visit
www.elosmedtech.com

-----------------------------------------------------------
http://news.cision.com/elos-medtech-ab/r/elos-medtech---subscription-of-...
http://mb.cision.com/Main/1719/2111655/582238.pdf

Författare WKR

Tala om vad ni tycker

Tala om vad ni tycker

Ni är just nu inne på en betaversion av nya aktiespararna. Lämna gärna feedback på vad ni tycker i formuläret nedan.